Abstract
Targeting α-adrenergic receptors synergizes with isotretinoin to suppress growth and to promote differentiation of neuroblastoma, revealing a combinatorial approach for more effective management of the disease and prevention of relapse.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have